SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 273.88 |
| Enterprise Value ($M) | 249.27 |
| Book Value ($M) | 107.98 |
| Book Value / Share | 3.50 |
| Price / Book | 2.54 |
| NCAV ($M) | 99.60 |
| NCAV / Share | 3.23 |
| Price / NCAV | 2.75 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.57 |
| Return on Assets (ROA) | -0.40 |
| Return on Equity (ROE) | -0.43 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 12.40 |
| Current Ratio | 12.40 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 112.14 |
| Assets | 120.52 |
| Liabilities | 12.54 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -67.10 |
| Net Income | -60.39 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -42.64 |
| Cash from Investing | 50.72 |
| Cash from Financing | -1.55 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Chione Ltd | 17.30 | -0.21 | |
| 13G/A | Perceptive Advisors Llc | 17.40 | 78.23 | |
| 13D/A | Ra Capital Management, L.p. | 27.10 | 73.52 | |
| 13G/A | Citadel Advisors Llc | 7.40 | ||
| 13G/A | Marshall Wace North America L.P. | 2.70 | -51.16 | |
| 13G/A | Sands Capital Ventures, LLC | 7.40 | -0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 9,898 | 43,662 | 22.67 | |
| 9,706 | 39,980 | 24.28 | |
| 26,590 | 71,334 | 37.28 | |
| 6,183 | 44,018 | 14.05 | |
| 8,886 | 49,807 | 17.84 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACAB – Atlantic Coastal Acquisition Corp. II | ACET – Adicet Bio, Inc. |
| ACIU – AC Immune SA | ADMA – ADMA Biologics, Inc. |
| AFMD – Affimed N.V. |
Financial data and stock pages provided by
Fintel.io